Luigi Celio Selected Research

Luigi Celio Research Topics

Disease

31	Nausea 03/2024 - 07/2008
31	Vomiting 01/2023 - 07/2008
14	Breast Neoplasms (Breast Cancer) 01/2021 - 05/2003
13	Neoplasms (Cancer) 09/2022 - 12/2002
2	Stomach Neoplasms (Stomach Cancer) 01/2009 - 12/2002
1	Weight Loss (Weight Reduction) 01/2023
1	Disease Progression 09/2022
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 09/2022
1	Cholangiocarcinoma 07/2021
1	Diarrhea 03/2020
1	Circulating Neoplastic Cells 01/2020
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020
1	Lymphatic Metastasis 01/2020
1	Neutropenia 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2009
1	Adenocarcinoma 12/2002

Drug/Important Bio-Agent (IBA)

22	Dexamethasone (Maxidex)FDA LinkGeneric 03/2024 - 07/2008
22	Palonosetron (Aloxi)FDA Link 03/2024 - 07/2008
14	AntiemeticsIBA 03/2024 - 07/2008
9	Cisplatin (Platino)FDA LinkGeneric 03/2024 - 07/2008
8	netupitantIBA 03/2024 - 08/2018
6	AnthracyclinesIBA 01/2021 - 02/2013
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 02/2013
4	Thrombin FDA Link 09/2022 - 01/2020
4	Aprepitant (Emend)FDA Link 01/2020 - 07/2008
3	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 01/2019
3	Capecitabine (Xeloda)FDA Link 03/2020 - 04/2005
3	Hormones (Hormone)IBA 03/2020 - 05/2003
3	Olanzapine (Zyprexa)FDA Link 06/2019 - 01/2017
2	fibrin fragment D (D-dimer)IBA 09/2022 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 09/2022 - 01/2020
2	Hemostatics (Antihemorrhagics)IBA 09/2022 - 01/2020
2	EmeticsIBA 10/2021 - 01/2017
2	Gemcitabine FDA Link 07/2021 - 01/2019
2	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 01/2021 - 01/2020
2	Neurokinin-1 Receptor AntagonistsIBA 01/2021 - 07/2019
2	Paclitaxel (Taxol)FDA LinkGeneric 06/2019 - 01/2013
2	Serotonin (5 Hydroxytryptamine)IBA 01/2017 - 07/2014
2	Toremifene (Fareston)FDA Link 06/2008 - 12/2004
1	ON 01910IBA 07/2021
1	Phosphotransferases (Kinase)IBA 07/2021
1	Radiation-Sensitizing AgentsIBA 07/2021
1	Transaminases (Aminotransferases)IBA 03/2020
1	Vinorelbine (Navelbine)FDA LinkGeneric 03/2020
1	Epithelial Cell Adhesion MoleculeIBA 01/2020
1	Fibrinogen (Factor I)FDA Link 01/2020
1	AntithrombinsIBA 01/2020
1	Phenobarbital (Luminal)FDA Link 01/2020
1	Prothrombin (Factor II)IBA 01/2020
1	Metoclopramide (Reglan)FDA LinkGeneric 01/2017
1	Streptozocin (Streptozotocin)FDA Link 01/2017
1	Carmustine (FIVB)FDA Link 01/2017
1	Mechlorethamine (Nitrogen Mustard)FDA Link 01/2017
1	Dacarbazine (DIC)FDA LinkGeneric 01/2017
1	Serotonin 5-HT3 Receptor AntagonistsIBA 10/2013
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2013
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2013
1	fosaprepitant FDA Link 01/2013
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2009
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2009
1	Complementary DNA (cDNA)IBA 06/2008
1	Estrogens (Estrogen)FDA Link 06/2008
1	Estrogen Receptor alphaIBA 06/2008
1	Estrogen ReceptorsIBA 06/2008
1	Estrogen Receptor betaIBA 12/2004
1	Messenger RNA (mRNA)IBA 12/2004
1	Estrogen Receptor Modulators (Antiestrogen)IBA 12/2004
1	Anastrozole (Arimidex)FDA LinkGeneric 05/2003
1	Letrozole (Femara)FDA LinkGeneric 05/2003
1	Insulin-Like PeptidesIBA 05/2003
1	exemestane (Aromasin)FDA Link 05/2003
1	Aromatase InhibitorsIBA 05/2003
1	Aminoglutethimide (Cytadren)FDA Link 05/2003
1	Interleukin-6 (Interleukin 6)IBA 05/2003
1	Pemetrexed (MTA)FDA Link 12/2002
1	Folic Acid AntagonistsIBA 12/2002

Therapy/Procedure

32	Drug Therapy (Chemotherapy) 03/2024 - 12/2002
9	Therapeutics 09/2022 - 12/2002
1	Adjuvant Chemotherapy 01/2020
1	Induction Chemotherapy 01/2020
1	Radiotherapy 08/2018
1	Aftercare (After-Treatment) 12/2004